. "Eis, V\u00E1clav" . . "6"^^ . "St\u00E1rka, Luboslav" . "Tissue and serum levels of principal androgens in benign prostatic hyperplasia and prostate cancer"@en . . . "Tissue and serum levels of principal androgens in benign prostatic hyperplasia and prostate cancer"@en . "9"^^ . "Steroids" . "Sachov\u00E1, Jana" . "Pr\u00E1ce sleduje rozd\u00EDly v hormon\u00E1ln\u00EDch hladin\u00E1ch z\u00E1kladn\u00EDch androgen\u016F u pacient\u016F s lok\u00E1ln\u00EDm a lok\u00E1ln\u011B pokro\u010Dil\u00FDm karcinomem prostaty a benign\u00ED hyperplazi\u00ED prostaty, korelaci mezi intraprostatick\u00FDmi a serov\u00FDmi hladinami hormon\u016F a v\u00FDznam stanoven\u00ED androgen\u016F pro predikci nemoci"@cs . . "Tissue and serum levels of principal androgens in benign prostatic hyperplasia and prostate cancer" . "Her\u00E1\u010Dek, Ji\u0159\u00ED" . "prostate cancer; benign prostatic hyperplasia; serum androgens; tissue androgens; epitestosterone; SHBG"@en . "[08684396F2E9]" . "72" . "RIV/00216208:11120/07:00000425!RIV08-MZ0-11120___" . "455234" . . "Mandys, V\u00E1clav" . "Kuncov\u00E1, Jitka" . "4"^^ . "US - Spojen\u00E9 st\u00E1ty americk\u00E9" . "11120" . "Tk\u00E1\u0148ov\u00E9 a s\u00E9rov\u00E9 hladiny z\u00E1kladn\u00EDch androgen\u016F u benign\u00ED hyperplazie prostaty a karcinomu prostaty"@cs . . "Tk\u00E1\u0148ov\u00E9 a s\u00E9rov\u00E9 hladiny z\u00E1kladn\u00EDch androgen\u016F u benign\u00ED hyperplazie prostaty a karcinomu prostaty"@cs . . . "RIV/00216208:11120/07:00000425" . . "P(NR8096)" . "Hill, M." . . . . . . . . "The aim of the study was to find out differences in hormonal levels of principal androgens in patients with localized and locally advanced prostate cancer and benign prostatic hyperplasia, their correlations between intraprostatic and serum levels and their value for disease prediction" . "Tissue and serum levels of principal androgens in benign prostatic hyperplasia and prostate cancer" . . . "375-380" . "Urban, Michael" . . "Hampl, R." . . "0039-128X" . "4" . "The aim of the study was to find out differences in hormonal levels of principal androgens in patients with localized and locally advanced prostate cancer and benign prostatic hyperplasia, their correlations between intraprostatic and serum levels and their value for disease prediction"@en .